Johnson & Johnson (NYSE:JNJ) is a multinational pharmaceutical, consumer products and medical equipment company which has stood the test of time. The company, which was founded in 1886, is one of the 30 companies which make up the Dow Jones Industrial Average. The company is well diversified from the inside; they have 3 main business segments with over 250 subsidiaries operating under them. Johnson & Johnson is known for maximizing shareholder value with a long history of hiking dividends and also initiating share buyback programs. They are also one of the last two companies in the United States with a AAA credit rating. With them trading at a relatively fair P/E ratio of 20.4, it is safe to say that JNJ is a strong buy and hold.
Johnson & Johnson: Buy And Hold Forever
5/15/17
Stories you Need to Know
- David Nevins Interviews Dr. Matthew Frieman, Associate Professor, University of Maryland School of Medicine
- Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
- Insmed Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
- Provention Bio Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
- Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial and Operational Results
- Pacira BioSciences Reports Full-Year and Fourth Quarter 2020 Financial Results
- MTBC Reports Record Full Year 2020 Results
- Aclaris Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update
- Merck to Acquire Pandion Therapeutics
- Madrigal Pharmaceuticals Reports 2020 Fourth Quarter and Full Year Financial Results and Highlights

